'Exciting' results from 'once-a-week not daily' HIV tablet trials
|
The single tablet combines islatravir and lenacapavir and
was just as effective at controlling HIV as currently available
medications. |
WCC will offer key input at International AIDS Conference in Brazil
Participants will include people living with HIV , researchers, policymakers, healthcare professionals, funders, media, and communities. Together, they ... View article...